Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market Size, Share & Trends Analysis Report by Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccine), Indication (Autoimmune ...

Newswise — As COVID-19 continues to evolve and mutate quickly, so do treatment options. While the best ways to prevent the spread of COVID-19 are vaccinations and booster vaccinations, several ...

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers a detailed analysis of the ...

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the growing problem of antimicrobial resistance, say scientists. A team lead by ...

Vanderbilt Health researchers and colleagues have isolated human monoclonal antibodies from previously infected individuals ...

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been published in the journal Molecular Biomedicine. The review provides ...

Could monoclonal antibodies be the key to tackling the growing problem of antimicrobial resistance? A team led by researchers at the University of Cambridge has developed a monoclonal antibody drug ...

Internist Vincent Martin, MD, said every primary care clinician should know about calcitonin gene-related peptide (CGRP) monoclonal antibodies for preventing migraines. These newer drugs are changing ...

Recently, the 'Key Rules for Inter-provincial Joint Procurement of Monoclonal Antibody Drugs Led by Anhui Province (Draft for Comments)' has been circulating within the industry. This proposal ...

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...

India, May 15 -- Calcitonin gene-related peptide (CGRP) inhibitor drugs used for migraine prevention may be linked to a lower risk of glaucoma, according to a report published May 6, 2026, in American ...

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...